china glp-1 More Chinese biotechs challenge dominance in diabetes China's #GLP1 market is evolving

October 8, 2022

Ali has seen

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis MARKET DYNAMICS Stringent cost and payer controls OPPORTUNITIES Impact Level Increasing studies on oral GLP-1 Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis Rapid expansion of manufacturing capacity is driving growth across the pharmaceutical market, especially for high-demand drugs like GLP-1 analogs

Seek professional advice: Not sure what you need

The researchers note that pricing structures may play a role, as lower doses are sometimes offered at reduced prices through self-pay channels